Mercury: Setting The PATTERN In Stone For Non-Detoxification
https://www.buergerwelle.de/pdf/mercury_autism_electricity.htm
--------
Here's a new study on mercury.
Dorothee
1: Neuro Endocrinol Lett. 2006 Aug, 27(4):415-23.
Mercury toxicity presenting as chronic fatigue, memory impairment and depression:diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006).
Wojcik DP, Godfrey ME, Christie D, Haley BE.Northland Environmental Health Clinic, 2 Dip Rd, Kamo, Whangarei, Northland, New Zealand. wojcik @wave.co.nz
In a group of 465 patients diagnosed as having chronic mercury toxicity (CMT), 32.3% had severe fatigue, 88.8% had memory loss, and 27.5% had depression. A significant correlation was found between CMT and the Apo-lipoprotein E4 genotype (p=0.001). An investigation into an additional 864 consecutively seen general practice patients, resulted in 30.3% having evidence consistent with CMT, and once again a significant correlation was found with the APO-E4 genotype (p=0.001). Removal of amalgam mercury fillings when combined with appropriate treatment resulted in a significant symptom reduction (p<0.001) to levels reported by healthy subjects.
PMID: 16891999 [PubMed - indexed for MEDLINE]
https://tinyurl.com/2u2smq
https://freepage.twoday.net/search?q=mercury
--------
Here's a new study on mercury.
Dorothee
1: Neuro Endocrinol Lett. 2006 Aug, 27(4):415-23.
Mercury toxicity presenting as chronic fatigue, memory impairment and depression:diagnosis, treatment, susceptibility, and outcomes in a New Zealand general practice setting (1994-2006).
Wojcik DP, Godfrey ME, Christie D, Haley BE.Northland Environmental Health Clinic, 2 Dip Rd, Kamo, Whangarei, Northland, New Zealand. wojcik @wave.co.nz
In a group of 465 patients diagnosed as having chronic mercury toxicity (CMT), 32.3% had severe fatigue, 88.8% had memory loss, and 27.5% had depression. A significant correlation was found between CMT and the Apo-lipoprotein E4 genotype (p=0.001). An investigation into an additional 864 consecutively seen general practice patients, resulted in 30.3% having evidence consistent with CMT, and once again a significant correlation was found with the APO-E4 genotype (p=0.001). Removal of amalgam mercury fillings when combined with appropriate treatment resulted in a significant symptom reduction (p<0.001) to levels reported by healthy subjects.
PMID: 16891999 [PubMed - indexed for MEDLINE]
https://tinyurl.com/2u2smq
https://freepage.twoday.net/search?q=mercury
rudkla - 5. Sep, 23:19
